The past six months haven't been kind to the investors in Intuitive Surgical (NASDAQ: ISRG) , a leader in robotic surgeries. To add to that, shares slumped further after the company reported its first-quarter 2022 earnings about a week ago.
Looking at the company's business performance, however, it feels like the market may be overreacting to Intuitive Surgical's near-term headwinds, presenting a timely opportunity for long-term investors to take a closer look at the company. Let's review why.
Intuitive Surgical, founded in 1995, pioneered the field of robotic-assisted surgeries. The company's da Vinci system provides surgeons an integrated suite of capabilities -- including 3D high-definition cameras, advanced surgical tools, monitoring stations, and software and analytics systems -- to perform complex procedures with exceptional precision. With its continuous innovation over the years, Intuitive Surgical has established itself as a clear leader in the industry.
For further details see:
Intuitive Surgical's Shares Just Got More Attractive